<DOC>
	<DOCNO>NCT01736527</DOCNO>
	<brief_summary>To ass level loteprednol etabonate ( LE ) tear fluid follow single topical instillation LE ophthalmic gel 0.5 % formulation healthy volunteer .</brief_summary>
	<brief_title>Tear Fluid Levels Loteprednol Etabonate Ophthalmic Gel 0.5 % Following Single Instillation</brief_title>
	<detailed_description />
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<criteria>Subjects must healthy volunteer physiologically normal anterior segment exhibit clinically significant biomicroscopy finding . Subjects must bestcorrected visual acuity 20/20 good eye . Subjects must active ocular disease allergic conjunctivitis . Subjects must Schirmer test ( without anesthesia ) â‰¥ 10mm 5 minute . Subjects must use topical ocular medication systemic medication acetaminophen . Male subject female subject childbearing potential . Female subject consider childbearing potential postmenopausal least 12 month permanently sterilize ( eg , tubal occlusion , hysterectomy , bilateral salpingectomy ) Subjects intraocular pressure le 5 mmHg great 22 mmHg type glaucoma . Subjects history ocular trauma , infection , inflammation within last 3 month . Subjects contraindication use , know sensitivity allergy , study drug ( ) component . Subjects wear contact lens day Visit 2 and/or Visit 3 study Subjects , Investigator 's discretion , presence significant illness could expect interfere study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>